Dispersion and stabilization of cochleate nanoparticles by Bozó, Tamás et al.
1 
 
Dispersion and stabilization of cochleate nanoparticles 
Tamás Bozóa, András Wachab, Judith Mihályb, Attila Bótab, Miklós, S. Z. Kellermayera,c* 
a
Semmelweis University, Department of Biophysics and Radiation Biology, 1094 Budapest, 
Tűzoltó u. 37-47., Hungary 
b
Biological Nanochemistry Research Group, Institute of Materials and Environmental 
Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences, 1117 
Budapest, Hungary, Magyar tudósok körútja 2. 
c
MTA-SE Molecular Biophysics Research Group, Semmelweis University, 1094 Budapest, 
Hungary, Tűzoltó u. 37-47. 
*corresponding author: kellermayer.miklos@med.semmelweis-univ.hu 
 
further e-mail addresses: 
T.B.: bozo.tamas@med.semmelweis-univ.hu 
A.W.: wacha.andras@ttk.mta.hu 
J.M.: mihaly.judith@ttk.mta.hu 
A.B.: bota.attila@ttk.mta.hu 
 
  
2 
 
Abstract 
Cochleates, calcium-stabilized membrane rolls of nanoscale diameter, promise a unique and 
efficient way of delivering lipid-soluble drugs, proteins or nucleic acids into biological 
systems because they protect the encapsulated material against enzymatic or chemical 
degradation. Self-aggregation, which typically arises during production and storage is a major 
obstacle that has so far precluded the development of an efficient cochleate-based drug-
delivery system. Here we show that citric acid, added transiently in a narrow concentration 
range, effectively disperses cochleate aggregates, stabilizes the disperse state for long-term 
storage and preserves the canonical ultrastructure and topological characteristics of cochleate 
nanoparticles.  
 
Keywords: cochleate, citrate, aggregation, stabilization, calcium, AFM, SAXS, FTIR 
  
3 
 
Introduction 
Cochleates are biocompatible, prospective drug-delivery vehicles. They are formed of 
spirally rolled bilayer sheets of negatively charged phospholipids stabilized by Ca
2+
 ions [1] 
so that the lipid-to-calcium binding ratio is thought to be 2:1 [1-3]. Several studies have 
shown their applicability as vaccine adjuvants [4-8] and carriers of antibiotics [9-12], 
systemic antimycotic agents [13-16] or factor VII for replacement in hemophilia A [17, 18]. 
However, their widespread use is severely hindered by a major technological obstacle: Ca
2+
 
ions, which are essential in the formation and maintenance of cochleate structure, consistently 
provoke aggregation of the particles. Aggregation is a serious drawback as it prevents the 
efficient separation from byproducts, the assessment and monitoring of cochleate formation, 
the modification and functionalization of cochleate surface and the manufacturing of a 
disperse, long-shelf-life pharmaceutical delivery system. A recent patent claimed to remedy 
this problem by adding half and half, milk, casein, albumin or methylcellulose [19]. 
However, the use of protein excipients may lead to aggravated problems of reduced stability 
and safety, and altered pharmacokinetics. Furthermore, methylcellulose caused only a partial 
disruption of aggregates. A long list of other polymeric materials (e.g., celluloses, gums, 
starches, etc.) has also been suggested as potential aggregation inhibitors, but feasibility is 
uncertain [19]. A very recent comparison between a novel, microfluidics-based strategy and 
conventional cochleate production methods has underlined that aggregation prevails as a 
major, unsolved problem [20]. In the present work we developed an efficient method of 
preparing stable, disperse cochleates. Dioleoyl phosphatidylserine liposomes, which are the 
precursors of cochleates, exhibit outstanding colloidal stability. However, upon the addition 
of Ca
2+
 they quickly form aggregates. Aggregation is caused by the surface-charge-modifying 
effect of Ca
2+ 
[21]. Therefore, by removing calcium the aggregates are expected to 
disassemble into their component nanoparticles. Removal of calcium, however, may lead to 
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unfavorable consequences, because it is the Ca
2+
 ions themselves that stabilize the inner 
structure of cochleates. Indeed, it has been known since the discovery of cochleates that upon 
the addition of EDTA, a strong chelator of calcium, cochleate particles loose their rolled-up 
structure and fuse into giant vesicles [1]. We hypothesized that a molecule with an affinity to 
Ca
2+
 lower than that of EDTA may be effective to disperse aggregates by removing Ca
2+
 ions 
from the outer surface of cochleates but leaving their inner structure intact. To test this 
hypothesis, we systematically examined sodium salts of mono-, bi- and tricarboxylic acids: 
acetate, tartrate and citrate. All of these acids are in their fully deprotonated form at pH 7.4, 
and their association constant to Ca
2+
 increases with the number of their carboxyl groups 
(Table 1.).  
We show that the addition of sodium citrate in a narrow concentration regime can fully 
disperse aggregated cochleates, and after citrate removal a colloidally stable system is 
obtained in which the topology and ultrastructure of the nanoparticles are well preserved. 
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Materials and methods 
Materials 
Dioleoyl phosphatidylserine (1,2-Dioleoyl-sn-Glycero-3-[Phospho-L-Serine], DOPS) was 
purchased from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA). All other chemicals 
were from Sigma Aldrich Kft. (Budapest, Hungary).  
Preparation of lipid vesicles and cochleates 
Thin DOPS lipid film was formed on the wall of a clean glass tube by evaporating the 
organic solvent from 500 µl 20 mg/ml DOPS/chloroform stock solution under a stream of N2. 
Organic solvent traces were removed by placing the tube in vacuum (<20 Hgmm) for 30 min. 
The lipid film was then hydrated with 100 μl aliquots of 100 mM TRIS (pH 7.4) to 1 ml final 
volume while vigorously vortexing. This multilamellar vesicle (MLV) suspension was 
extruded 41 times through a polycarbonate membrane filter with 100 nm pore diameter in an 
AvantiPolar Mini Extruder (Avanti Polar Lipids, Inc., Alabaster, AL, USA). The resultant 
small unilamellar vesicle (SUV) suspension of 12.4 mM DOPS concentration was diluted 1 
to 1 with 100 mM TRIS (pH 7.4), and 400 µl of this solution was dialyzed for 24 hours 
against 100 ml 6.2 mM CaCl2, 100 mM TRIS (pH 7.4). The obtained cochleate suspension 
had a nominal 6.2 mM concentration for both DOPS and Ca
2+
. The sample was stored at 
room temperature until use. The preparatory steps were done at room temperature. 
Dispersion of cochleates 
Aqueous solutions of the tested potential dispersing agents (sodium acetate trihydrate, sodium 
tartrate dihydrate, trisodium citrate dihydrate, disodium edetate) were prepared in a buffer 
containing 100 mM TRIS (pH 7.4).  We added 10 μl of the solution to 10 μl cochleate sample 
and mixed intensively by drawing through a narrow pipette tip 50 times. Samples were 
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examined within 10 minutes after being mixed with dispersing agents.  The actual 
concentrations of dispersing agents are given in figure captions. Control experiments were 
carried out with buffer only.  
To obtain a stabilized colloidal system, 20 μl of cochleate sample freshly dispersed with 
citrate was diluted with 80 μl of 100 mM TRIS (pH 7.4), then clarified by centrifugation 
(Heraeus Biofuge Pico, Life Technologies Magyarország Kft., Budapest, Hungary, 12800 x 
g, at 25±1°C, 5 minutes). The supernatant was gently removed and the pellet was 
resuspended in 90 μl of 100 mM TRIS (pH 7.4). The procedure was repeated 3 times. To test 
the effect of Ca
2+
 on resuspended cochleates, the pellets were resuspended with 100 mM 
TRIS (pH 7.4) containing 6.2 mM CaCl2. 
Phase contrast microscopy 
Micrographs were recorded with a Nikon Eclipse Ti-U inverted microscope (Auro-Science 
Kft., Budapest, Hungary) equipped with a uEye UI 1220 LE digital camera (IDS Imaging 
Development Systems GmbH, Obersulm, Germany) using either a 20x or a 40x Nikon S 
Planfluor phase contrast objective. 
Atomic force microscopy 
For AFM imaging 10 µl of the control or dispersed cochleate sample was diluted with 50 µl 
100 mM TRIS (pH 7.4) then applied to the substrate and, after 1 minute incubation, washed 
gently with MilliQ water and dried in a stream of N2 gas. For control cochleates freshly 
cleaved mica sheets were used as substrate. In the case of dispersed cochleates we used mica 
sheets pre-coated with 100 μl 0.01% poly-L-lysine for 20 min. Cochleates were imaged with 
a Cypher instrument (Asylum Research, Santa Barbara, CA) with 0.5 to 2.5 Hz line-scanning 
rate in air at 29±1°C. A silicon cantilever (OMCL AC-160TS, Olympus, Japan) was used in 
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non-contact mode, oscillated at its resonance frequency (300-320 kHz, typically). Images 
with 512 x 512 pixel dimensions were collected and analyzed with the built-in algorithms of 
the AFM driver software.  
Small-angle X-ray scattering 
Small-angle X-ray scattering (SAXS) measurements on the cochleate samples were carrried 
out with a CREDO instrument integrated with a GeniX
3D
 Cu ULD microfocus system 
(Xenocs SA, Sassenage, France) for producing X-rays and a Pilatus-300k CMOS hybrid pixel 
position sensitive detector (Dectris Ltd, Baden, Switzerland) [22, 23]. The recorded 2D 
scattering patterns were subjected to the standard on-line data reduction procedure of the 
instrument control software. Corrections were made for instrumental background, detector 
flatness, and sample self-absorption. The abscissa was calibrated with mesoporous silica into 
scattering variable units q=(4∙π∙sinθ)∙λ-1, where 2θ is the scattering angle and λ=0.154 nm is 
the X-ray wavelength of Cu Kα radiation. Intensity was transformed from count rates to 
differential scattering cross-section (cm
-1∙sr-1) units using a pre-calibrated glassy carbon 
specimen. 
The MLV sample was used without further processing. Cochleate samples were clarified by 
centrifugation (see above). All the samples were filled into borosilicate capillaries of cca. 1 
mm outer diameter and 0.01 mm wall thickness and centrifuged gently (Eppendorf Minispin 
microcentrifuge, Eppendorf  AG, Hamburg, Germany, 67 x g; at 25±1°C, 5 min) to prevent 
sedimentation during experiment. The total exposure time was at least 2 hours in each case, 
carried out in several 5-minute exposures in order to monitor sample stability. 
Infrared spectroscopy 
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ATR-FTIR spectra were collected with a Varian 2000 FTIR Scimitar Series (Varian Inc., 
Paolo Alto, CA) spectrometer equipped with a ‘GoldenGate’ (Specac Ltd., London, UK) 
single reflection diamond ATR accessory. The measurements were performed at room 
temperature: 5 μl sample was mounted on the top of the diamond ATR crystal. DOPS SUV 
sample was applied directly, while cochleate samples were clarified by centrifugation (see at 
dispersion of cochleates) and once more centrifuged at 12800 x g for 5 minutes. The 
supernatant was removed and the resuspended pellet was used. IR spectra were recorded both 
on hydrated lipid systems and as dry films obtained on diamond ATR surface after solvent 
evaporation. We collected 128 scans at a resolution of 2 cm
-1
. ATR correction was executed 
after each data collection. All spectral manipulations were performed using the GRAMS/32 
software package (Galactic Industries Incorporation, USA). 
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Results and Discussion 
Standard cochleate preparation yields aggregates 
Upon the addition of calcium to DOPS vesicles a milky suspension formed that contained 
micron-size aggregates of irregular shape (Figure 1. A.). Elongated objects identified as 
cochleates protruded from the aggregates the bulk of which consisted of aggregated vesicles 
(Figure 1. B and Supplement figure 1.). Cochleates and vesicles were strongly bound to each 
other and could not be dispersed by either dilution or intense shaking (Supplement figure 2.). 
Citrate disperses aggregates 
[21]  
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To test the hypothesis that a molecule with appropriate affinity to Ca
2+
 may be effective to 
disperse aggregates, we added different carboxylic acids to cochleate samples. These acids 
are fully deprotonated at pH 7.4, and their affinity to Ca
2+
 increases with the number of their 
carboxyl groups (Table 1.). Acetate did not cause any disassembly of the aggregates even at a 
concentration of 500 mM (Supplement figure 3. A). Treatment with 500 mM tartrate led only 
to a partial disassembly (Supplement figure 3. B). By contrast, citrate effectively dispersed 
the cochleates (Figure 2. A). Furthermore, the dispersing effect of citrate was concentration-
dependent (Supplement figure 4.). At the given experimental lipid and Ca
2+
 concentrations 
the optimal citrate concentration range was 200-212.5 mM. Below this concentration regime 
aggregates disassembled only partially, while above this regime the cochleates transformed 
into giant vesicles (Supplement figure 4.). Thus, there is a relatively narrow concentration 
range in which citric acid functions as an efficient dispersing agent of cochleate-vesicle 
aggregates.  
Assurance of long-term cochleate stability 
Figure 2. B. shows a cochleate sample 24 hours after it was dispersed by citrate. Individual 
cochleates, which were clearly distinguishable after citrate addition (Figure 2. A), were no 
longer observed. Rather, they transformed into clusters of giant vesicles. Thus, citrate, even 
when applied in the optimal dispersing concentration, disintegrates cochleates with time by 
extracting the calcium ions from in between the membrane layers. To avoid this effect, we 
removed excess citrate by centrifuging the sample immediately following the complete 
dispersion of cochleates then resuspended the pellet in 100 mM TRIS (pH 7.4). The 
cochleates in this sample preserved their structure, and, although sedimented with time, by 
stirring they could be well dispersed even after one month of storage at 25±1°C (Figure 2. C). 
If Ca
2+
 concentration was restored in the disperse suspension, cochleate aggregation took 
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place again (Supplement figure 5.). Thus, by removing Ca
2+
, citrate treatment altered the 
surface properties of cochleates and thereby prevented their aggregation. 
Citrate treatment preserves the high-resolution structure of cochleates 
To test whether the cylindrical particles found in the citrate-treated samples (Figures 2.A and 
C) preserved the canonical cochleate structure, we carried out high-resolution AFM 
measurements. We were unable to discern any appreciable structural differences between the 
control (Figure 1. B.) and citrate-treated cochleate particles (Figure 3. and Supplement figure 
6.). Both control and citrate-stabilized cochleates displayed features consistent with their 
presumed cochleate model [1, 29, 30]. Accordingly, both samples contained elongated 
particles with gradually varying diameter across their longitudinal axis. The edges of lipid 
layers were clearly seen on their surface indicating a roll-like arrangement. There was only 
one striking difference between the samples: whereas in control samples the cochleates were 
often part of an aggregate composed of roll-like and vesicular structures (Figure 1.B.), in the 
citrate-treated sample the particles were systematically dispersed (Figure 3. and Supplement 
figure 6.). Thus, citrate can effectively disperse cochleates without damaging their unique 
structure.  
Although the citrate-treated and control cochleates are topologically essentially identical, 
ultrastructural differences might be present. To explore the effect of citrate on the internal 
structure of cochleates we used small-angle x-ray scattering (SAXS) which can reveal the 
changes in correlation and ordering of vicinal bilayers. Scattering was measured in an interval 
corresponding to the range of bilayer thickness and periodicity (0.3 - 6 nm
-1
). The 
investigated samples were a DOPS multilamellar vesicle suspension, a control sample with 
aggregated cochleate particles, another two with 100 mM and 212.5 mM citrate, and finally 
one containing 50 mM EDTA instead of citrate (Figure 4). Notably, at a citrate concentration 
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of 100 mM cochleates were partially dispersed, while at 212.5 mM dispersion was complete 
(Supplement figure 4.) and the addition of 50 mM EDTA led to the transformation of 
cochleates into giant vesicles (Supplement figure 7.). The hydrated DOPS system, which is 
expected to form multilamellar vesicles, shows a very broad signal between 0.5 nm
-1
 < q < 3 
nm
-1
 (Figure 4. A) typical for entirely uncorrelated multilamellar systems [31]. The absence 
of long-range ordering is caused by the electrostatic repulsion of the neighbouring bilayers 
due to the net negative charge of the phosphatidylserine headgroups. The addition of Ca
2+
 
caused a drastic change in the layer organization as seen from the sharp, equidistant Bragg-
reflections at 1.2, 2.4 and 3.77 nm
-1
 (Figure 4. B). The highly ordered and periodic lamellar 
state corresponds to the cochleate and has a repeat distance of 5.15 nm, similarly to the 
findings of Nagarsekar et al. [20].  This structure is retained even following the addition of 
citrate (Figure 4. C and D). The peak positions align well with the control cochleate sample 
and correspond to a 5.18 nm repeat distance. The observed loss in intensity was likely caused 
by the different sedimentation rate of samples which resulted in different amounts of lipid 
material in the lower region of the capillaries where the X-ray beam was focused. At high 
citrate concentration the SAXS signal monotonically increases towards small angle intervals, 
which is attributed to the diffuse scattering by the smaller particles emerging during the 
disaggregation process (Figure 4. D). This feature was absent in control cochleate (Figure 4. 
B) and cochleate + 100 mM citrate (Figure 4. C) samples, because the scattering by the large 
aggregates made little contribution in this region. The addition of EDTA induced significant 
changes in bilayer structure (Figure 4. E). The overall scattering curve resembles that of 
uncorrelated bilayers, and a single Bragg peak at 0.92 nm
-1
 appeared. This reflection 
corresponds most likely to the small amount of regular multilamellar bilayer stacks present in 
the system. The periodicity (6.8 nm) is significantly greater than that in cochleates (5.15 nm) 
indicating that layer packing is less tight than in cochleates. In summary, applying citrate at a 
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concentration optimal to disperse aggregated cochleates does not modify the inner structure 
of the membrane rolls. 
Citrate removes Ca
2+
 from cochleate-surface head groups 
To reveal the molecular mechanisms of the dispersing effect of citrate, we carried out 
infrared spectroscopy measurements with a focus on the phosphate (1250-100 cm
-1
, Figure 5. 
A), methylene (3000-2800 cm
-1
, Figure 5. B) and ester carbonyl (1760-1690 cm
-1
, Figure 5. 
C) stretching vibrations which are sensitive to phosphate head group hydration, acyl-chain 
order and glycerol-group hydration, respectively. 
The asymmetric and symmetric phosphate PO2
-
 stretching bands at 1219 and 1065 cm
-1
, 
respectively, were rather featureless for the DOPS SUV system (Figure 5. A, spectrum a). In 
control cochleates the PO2
-
 asymmetric stretching band shifted from 1219 to 1236 cm
-1
 and 
the symmetric PO2
-
 stretching band split to four components (1111, 1102, 1075 and 1063 cm
-
1
, Figure 5. A, spectrum b). These changes point at the dehydration of the phosphate group 
and the formation of a bidentate complex between the Ca
2+
 ion and the phosphate ester [32]. 
Addition of 100 mM citrate did not cause any spectral changes in the phosphate head group 
region (Figure 5. A, spectrum c). At 212.5 mM citrate concentration the relative intensities of 
phosphate stretching bands, characteristic to Ca
2+
-DOPS interaction, decreased (Figure 5. A, 
spectrum d), implying that a fraction of Ca
2+
-phosphate complexes had broken up. Addition 
of 50 mM EDTA led to the disappearance of characteristic phosphate bands of Ca
2+
-
phosphate interaction. Note that both citrate and EDTA have absorption bands in this region, 
the subtractions of which decreased the quality of the spectra. 
In DOPS liposomes antisymmetric (νasCH2) and symmetric (νsCH2) methylene stretching 
vibrations dominated at 2924 and 2854 cm
-1
, respectively (Figure 5. B, spectrum a).  
14 
 
In control cochleates the methylene stretching band positions shifted towards lower 
wavenumbers (Figure 5. B, spectrum b) indicating a tighter lipid packing, which may be 
attributed to the strong interaction of Ca
2+
 with lipid head groups. Addition of 100 mM citrate 
had no observable effect in this spectral region (Figure 5. B, spectrum c). However, at a 
dispersing citrate concentration (212.5 mM) the position of both the asymmetric and 
symmetric stretching bands shifted to higher wavenumbers approaching those of the Ca
2+
-
free liposomes (Figure 5. B, spectrum d). Thus, a fraction of lipids became less tightly 
packed. Upon adding 50 mM EDTA a further increase of νsCH2 could be observed as a result 
of acyl-chain perturbation leading to a lipid bilayer structure, the packing of which is similar 
to that of liposomes (Figure 5. B, spectrum e).In the spectral region sensitive to ester carbonyl 
vibrations, DOPS liposomes (Figure 5. C, spectrum a) displayed a broad band that could be 
deconvoluted into two components (at ~1736 cm
-1
, and at ~1725 cm
-1
) assigned to differently 
hydrated subpopulations of the two carbonyl groups [33]. Upon Ca
2+
 addition, four νC=O 
stretching bands became distinct at 1745, 1729, 1720 and 1704 cm
-1
 (Figure 5. C, spectrum 
b). The lower wavenumbers point at the formation of new hydrogen bonds, while band 
narrowing is due to a significant reduction in motional freedom caused most likely by the 
immobilization of polar headgroups due to Ca
2+
 complexation [34, 35]. Addition of 100 mM 
citrate did not alter the IR spectrum (Figure 5. B, spectrum c). At the dispersing citrate 
concentration (212.5 mM), however, the intensities of the narrow νC=O stretching bands, 
peculiar to the Ca
2+
-DOPS complexes, decreased, and a broad band centered at 1728 cm
-1
, 
characteristic to hydrated DOPS lipids, appeared (Figure 6. d). Upon the addition of 50 mM 
EDTA the carbonyl stretching region of the IR spectrum reverted back to that of DOPS 
liposomes, and the spectral features characteristic to cochleates disappeared (Figure 6. E). 
Similar trends were observed in dry film spectra (Supplement figure 8.) with the exception 
that the narrow νC=O stretching bands, specific to Ca2+-bound phospholipids, were more 
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dominant even at 212.5 mM citrate (Supplement figure 8. d). Because under dry film 
conditions the direct interactions are more important, these bands underpin that Ca
2+
-bound 
head groups were present even after the addition of 212.5 mM citrate. Altogether the FTIR 
spectroscopy results indicate that citrate applied in dispersing concentration removes Ca
2+
 
from a fraction of the lipid head groups. Since cochleates with preserved structure prevailed 
(Figures 2. and 3.) and FTIR spectra also showed the presence of Ca
2+
-head group complexes 
in citrate-dispersed samples (Figure 5., spectra d), the Ca
2+
-deprived fraction may correspond 
to both the head groups of vesicles and cochleate-surface head groups. Nevertheless, within 
the dispersing citrate concentration range, the calcium-bound state of the internal lipid head 
groups of cochleates is left intact. Notably we cannot exclude that some cochleates 
disintegrated upon addition of citrate at optimal dispersing concentration. This may happen 
due to local concentration inhomogeneities during mixing the sample with citrate. 
 
Conclusions 
In conclusion, citric acid, an inexpensive, low-molecular-weight and biocompatible material, 
can be effectively used as a dispersing and stabilizing agent in cochleate nanotechnology. 
Citrate apparently removes Ca
2+
 from the cochleate surface rapidly and disrupts calcium-
dependent cross-links between the particles. Removal of cross-links and an increased 
electrostatic repulsion between the particles leads to the rapid disassembly of aggregates. By 
contrast, it takes a longer time for citrate to extract Ca
2+
 incorporated between the membrane 
layers. Therefore, the unrolling of cochleates can be prevented by removing excess citrate 
following aggregate disassembly. Altogether, a disperse cochleate sample with long-term 
stability is obtained. The citrate-based dispersion and stabilization method is likely to 
contribute to the development of efficient cochleate-based drug delivery systems.  
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Figures 
 
Figure 1. Structure of nascent cochleates. (A) Phase contrast micrograph of dialyzed 
cochleates. White arrowheads point at elongated structures identified as cochleates. (B) 
Amplitude-contrast AFM image of a cochleate aggregate.  
 
 
Figure 2. Phase contrast micrographs of citrate-treated cochleate samples. (A) Cochleates 
dispersed in 212.5 mM sodium citrate. (B) The same sample after 24 h of incubation at room 
temperature. (C) Same sample as in (A) but centrifuged and resuspended in 100 mM TRIS 
pH=7.4 buffer immediately following citrate treatment. 
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Figure 3. AFM amplitude images of a citrate-stabilized cochleates. 
 
 
 
Figure 4. SAXS diffractograms of (A) DOPS MLV-s, (B) control cochleates, (C) cochleates 
+ 100 mM citrate, (D) cochleates + 212.5 mM citrate, (E) cochleates + 50 mM EDTA. 
Diffractograms are gradually shifted along relative intensity axis for better display. 
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Figure 5. The (A) phosphate, (B) C-H and (C) ester carbonyl stretching region of the infrared 
spectra of hydrated lipid systems (corresponding buffer spectra are subtracted). (a) DOPS 
SUV, (b) cochleates; (c) cochleates + 100mM citrate, (d) cochleates + 212.5 mM citrate; (e) 
cochleates + 50 mM EDTA. 
 
